News
- Author:
- Neil Osterweil
Publish date: February 11, 2013
Major finding: Optimal depth of endotracheal tube insertion in centimeters equals 0.75 times ulnar length in centimeters plus 4.4.Data source: Pro...
News
- Author:
- Neil Osterweil
Publish date: February 5, 2013
Major finding: Median tidal volume delivered to mechanically ventilated patients in the ED was 8.8 mg/kg per IBW, above the recommended upper limi...
Article
- Author:
- Neil Osterweil
Publish date: February 1, 2013
News
- Author:
- Neil Osterweil
Publish date: January 30, 2013
Major Finding: The cumulative incidence of grade 2-4 acute graft-versus-host disease at day 100 after hematopoietic stem-cell transplant was 22% f...
News
- Author:
- Neil Osterweil
Publish date: January 30, 2013
Major finding: Of 38 patients prescribed dabigatran during their hospital stay, 5 (13%) received it for unlabeled indications.Data source: A prosp...
News
- Author:
- Neil Osterweil
Publish date: January 30, 2013
Major Finding: Among patients with Hodgkin’s lymphoma whose PET scans were negative for residual disease following three cycles of ABVD chem...
News
- Author:
- Neil Osterweil
Publish date: January 29, 2013
News
- Author:
- Neil Osterweil
Publish date: January 28, 2013
Major finding: Ventilator-associated pneumonia event rates dropped from 10.8 to 5.3/1,000 ventilator days when evaluations for patient extubation ...
News
- Author:
- Neil Osterweil
Publish date: January 28, 2013
Major finding: A comprehensive hospital-wide infection reduction program resulted in an 18% decrease in antibiotic days and 32% reductions in both...
News
- Author:
- Neil Osterweil
Publish date: January 25, 2013
Major Finding: At a median of 41 months’ follow-up in patients with intermediate to high-risk diffuse large B-cell lymphoma, 3-year progress...
News
- Author:
- Neil Osterweil
Publish date: January 25, 2013
Major Finding: In a phase II study, lenalidomide added to CHOP chemotherapy and rituximab produced a 92% overall response rate in elderly patients...
News
- Author:
- Neil Osterweil
Publish date: January 11, 2013
Major Finding: The 3-year overall survival rate for 100 patients with stage IA NSCLC treated with stereotactic body radiation therapy was 59.9%, c...
Article
- Author:
- Neil Osterweil
Publish date: January 1, 2013
News
- Author:
- Neil Osterweil
Publish date: December 13, 2012
Major Finding: Patients with chronic hepatitis B who were treated with entecavir and pegylated interferon alfa-2a had a greater decline in HBV DNA...
News
- Author:
- Neil Osterweil
Publish date: December 13, 2012
Major Finding: In cirrhotic and noncirrhotic patients treated with boceprevir, pegylated interferon alfa-2b, and ribavirin, 57% of patients with c...
